MiR-1290 promotes cancer progression by targeting nuclear factor I/X(NFIX) in esophageal squamous cell carcinoma (ESCC)
- Type
- Retraction
- Notice date
- 1/30/2024 0:00
- Journal
- Biomedicine & Pharmacotherapy
- Publisher
- Elsevier
- Notice DOI
- 10.1016/j.biopha.2024.116189
- Original paper DOI
- 10.1016/j.biopha.2015.10.005